Oxidative stress in Alzheimer disease

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works

Protein Oxidation in Aging, Disease, and Oxidative Stress

Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,339 · see citing works

[37] Carbonyl assays for determination of oxidatively modified proteins

Levine, R. L., Williams, J. A., Stadtman, E. R., & Shacter, E. B. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,707 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · see citing works

The oxidative environment and protein damage

Davies, M. J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.08.007 · Cited by 1,392 · see citing works

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256 · see citing works

Oxidative stress and Alzheimer disease

Christen, Y. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.621s · Cited by 1,158 · see citing works

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200114002 · Cited by 1,039 · see citing works

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · see citing works

4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

Sayre, L., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,032 · see citing works

Oxidative damage in Alzheimer's

Smith, M. A., Perry, G. L., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. W. (1996) · Nature · doi:10.1038/382120b0 · Cited by 897 · see citing works

Oxidative Stress and Neurotoxicity

Sayre, L. M., Perry, G. L., & Smith, M. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 868 · see citing works

Protein carbonylation, cellular dysfunction, and disease progression

Dalle‐Donne, I., Aldini, G., Carini, M., Colombo, R., Rossi, R., & Milzani, A. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00407.x · Cited by 836 · see citing works

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806 · see citing works

A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781 · see citing works

RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

Nunomura, A., Perry, G., Pappolla, M., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 768 · see citing works

Does oxidative damage to DNA increase with age?

Hamilton, M. L., Van Remmen, H., Drake, J. A., Yang, H., Guo, Z. M., Kewitt, K., Walter, C. A., & Richardson, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171202698 · Cited by 768 · see citing works

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680 · see citing works

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644 · see citing works

Oxidative damage to DNA: do we have a reliable biomarker?

Collins, A. R., Dušinská, M., Gedik, C. M., & Štětina, R. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s3465 · Cited by 630 · see citing works

Identification of Glyoxal and Arabinose as Intermediates in the Autoxidative Modification of Proteins by Glucose

Wells‐Knecht, K. J., Zyzak, D. V., Litchfield, J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00011a027 · Cited by 594 · see citing works

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.

Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565 · see citing works

Type 2 diabetes mellitus, cognitive impairment and dementia

Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562 · see citing works

Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease

Lovell, M. A., & Markesbery, W. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm821 · Cited by 515 · see citing works

Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain.

Forster, M. J., Dubey, A., Dawson, K. M., Stutts, W. A., Lal, H., & Sohal, R. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4765 · Cited by 494 · see citing works

Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease

Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 479 · see citing works

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs

Breitner, J. C. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00049-k · Cited by 466 · see citing works

Radical AGEing in Alzheimer's disease

Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93897-7 · Cited by 462 · see citing works

Neuronal and glial calcium signaling in Alzheimer’s disease

Mattson, M. P., & Chan, S. L. (2003) · Cell Calcium · doi:10.1016/s0143-4160(03)00128-3 · Cited by 454 · see citing works

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease

Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., & Brandt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.51 · Cited by 446 · see citing works

Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal

Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439 · see citing works

Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B. O., Petersen, R. B., & Perry, G. L. (1994) · PubMed Central · Cited by 425 · see citing works

The Relation Between Antioxidants and Memory Performance in the Old and Very Old

Perrig, W. J., Perrig, P., & Stähelin, H. B. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb01476.x · Cited by 344 · see citing works

Glutathione-dependent detoxification of α-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors

Thornalley, P. J. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00157-9 · Cited by 308 · see citing works

Increased DNA Oxidation and Decreased Levels of Repair Products in Alzheimer's Disease Ventricular CSF

Lovell, M. A., Gabbita, S. P., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720771.x · Cited by 291 · see citing works

Age-related changes in glutathione and glutathione-related enzymes in rat brain

Zhu, Y., Carvey, P. M., & Ling, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.063 · Cited by 279 · see citing works

Vitamin E and Alzheimer disease: the basis for additional clinical trials

Grundman, M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.630s · Cited by 267 · see citing works

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

Hoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265 · see citing works

Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance

Curb, J. D., Rodríguez, B. L., Abbott, R. D., Petrovitch, H., Ross, G. W., Masaki, K., Foley, D. J., Blanchette, P. L., Harris, T. B., Chen, R., et al. (1999) · Neurology · doi:10.1212/wnl.52.5.971 · Cited by 231 · see citing works

Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine

Smith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N. W., & Perry, G. L. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222 · see citing works

Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain

Mecocci, P., Beal, M. F., Cecchetti, R., Polidori, M. C., Cherubini, A., Chionne, F., Avellini, L., Romano, G., & Senin, U. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815160 · Cited by 215 · see citing works

H2o2 and 4-hydroxynonenal mediate amyloid β-induced neuronal apoptosis by activating jnks and p38mapk

Tamagno, E., Robino, G., Obbili, A., Bardini, P., Aragno, M., Parola, M., & Danni, O. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00059-6 · Cited by 201 · see citing works

Increased lipoprotein oxidation in alzheimer’s disease

Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Stürenburg, H.-J., Mann, U. M., Müller‐Thomsen, T., & Beisiegel†, U. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00247-6 · Cited by 201 · see citing works

Carbonyl Toxicology and Alzheimer's Disease

Picklo, M. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194 · see citing works

Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type

Gsell, W., Conrad, R., Hickethier, M., Sofic, E., Frölich, L., Wichart, I., Jellinger, K. A., Moll, G. H., Ransmayr, G. N., Beckmann, H., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031216.x · Cited by 175 · see citing works

The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease

Selley, M. L. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00327-x · Cited by 175 · see citing works

New biomarkers of Maillard reaction damage to proteins

Wells‐Knecht, K. J., Brinkmann, E., Wells-Knecht, M. C., Litchfield, J., Ahmed, M., Reddy, S., Zyzak, D. V., Thorpe, S. R., & Baynes, J. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.41 · Cited by 170 · see citing works

Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state

Calabrese, V. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.01.003 · Cited by 162 · see citing works

The Risk of Dementia among Persons with Diabetes Mellitus: A Population‐Based Cohort Studya

Leibson, C. L., Rocca, W. A., Hanson, V., CHA, R., Kokmen, E., O’Brien, P. C., & Palumbo, P. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48496.x · Cited by 152 · see citing works

Lipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease

Arlt, S., Beisiegel†, U., & Kontush, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00009 · Cited by 151 · see citing works

Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases

Luo, Y., Bond, J. D., & Ingram, V. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9705 · Cited by 141 · see citing works

Studies on lipid peroxidation and protein oxidation in the aging brain

Cini, M., & Moretti, A. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80007-e · Cited by 137 · see citing works

Metal ions and oxidative protein modification in neurological disease.

Sayre, L. M., Moreira, P. I., Smith, M. A., & Perry, G. L. (2005) · PubMed · Cited by 135 · see citing works

4-Hydroxynonenal, a Product of Lipid Peroxidation, Damages Cholinergic Neurons and Impairs Visuospatial Memory in Rats

Bruce‐Keller, A. J., Li, Y., Lovell, M. A., Kraemer, P. J., Gary, D. S., Brown, R. R., Markesbery, W. R., & Mattson, M. P. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199803000-00007 · Cited by 133 · see citing works

Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A

Arendt, T., Holzer, M., Fruth, R., Brückner, M. K., & Gärtner, U. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00347-l · Cited by 132 · see citing works

Free radicals in Alzheimer’s disease

Retz, W., Gsell, W., Münch, G. W., Rösler, M., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_22 · Cited by 125 · see citing works

Alterations in oxidative stress scavenger system in aging rat brain and lymphocytes

Sandhu, S. K., & Kaur, G. (2002) · Biogerontology · doi:10.1023/a:1015643107449 · Cited by 115 · see citing works

Ascorbic acid-induced crosslinking of lens proteins: evidence supporting a Maillard reaction

ORTWERTH, B. J., & Olesen, P. R. (1988) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(88)90292-0 · Cited by 115 · see citing works

The Effect of Aging on Glutathione and Cysteine Levels in Different Regions of the Mouse Brain

Chen, T. S., Richie, J. P., & Lang, C. A. (1989) · Experimental Biology and Medicine · doi:10.3181/00379727-190-42879 · Cited by 110 · see citing works

Transition metal‐mediated glycoxidation accelerates cross‐linking of β‐amyloid peptide

Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P. F., & Münch, G. W. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01452.x · Cited by 108 · see citing works

Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain

Ramassamy, C., Krzywkowski, P., Averill‐Bates, D. A., Lussier‐Cacan, S., Théroux, L., Christen, Y., Davignon, J., & Poirier, J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00268-0 · Cited by 97 · see citing works

Gender difference in glutathione metabolism during aging in mice

Wang, H. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00036-6 · Cited by 89 · see citing works

Investigations on oxidative stress and therapeutical implications in dementia

Durany, N., Münch, G. W., Michel, T. M., & Riederer, P. F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014177 · Cited by 88 · see citing works

Multiplexed Proteomic Analysis of Oxidation and Concentrations of Cerebrospinal Fluid Proteins in Alzheimer Disease

Korolainen, M. A., Nyman, T. A., Nyyssönen, P., Hartikainen, S., & Pirttilä, T. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078014 · Cited by 85 · see citing works

Age-associated changes in protein oxidation and proteasome activities in rat brain: Modulation by antioxidants

Mohsen, M. M. A. E., Iravani, M. M., Spencer, J. P. E., Rose, S., Fahim, A. T., Motawi, T. K., Ismail, N. A. F., & Jenner, P. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.201 · Cited by 83 · see citing works

Risk Factors for Vascular Disease and Dementia

Breteler, M. M. B., Bots, M. L., Ott, A., & Albert Hofman, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022428 · Cited by 82 · see citing works

Age-Related Elevation of Lipid Peroxidation Products: Diminution of Superoxide Dismutase Activity in the Central Nervous System of Rats

Gupta, A., Hasan, M. N., Chander, R., & Kapoor, N. K. (2009) · Gerontology · doi:10.1159/000213277 · Cited by 80 · see citing works

Cognitive impairment and oxidative stress in the elderly: Results of epidemiological studies

Berr, C. (2000) · BioFactors · doi:10.1002/biof.5520130132 · Cited by 78 · see citing works

Down‐regulation of γ‐glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging

Liu, R.-M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10217 · Cited by 77 · see citing works

Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress?

Münch, G. W., Gerlach, M., Sian, J., Wong, A. O., & Riederer, P. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440713 · Cited by 73 · see citing works

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

Münch, G. W., Taneli, Y., Schraven, E., Schindler, U., Schinzel, R., Palm, D., & Riederer, P. F. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260940 · Cited by 69 · see citing works

Lipoproteins and lipid peroxidation in Alzheimer's disease.

Bassett, C. N., & Montine, T. J. (2003) · PubMed · Cited by 67 · see citing works

Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease

Li, Y. M., & Dickson, D. W. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00266-8 · Cited by 62 · see citing works

Free radicals in Alzheimer’s dementia: currently available therapeutic strategies

Rösler, M., Retz, W., Thome, J., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_21 · Cited by 60 · see citing works

Inhibitory Effects of Tenilsetam on the Maillard Reaction

Shoda, H., Miyata, S., Liu, B.-F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M., & Kasuga, M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5151 · Cited by 59 · see citing works

A tombstone in Alzheimer's?

Mattson, M. P., Carney, J. M., & Butterfield, D. A. (1995) · Nature · doi:10.1038/373481a0 · Cited by 58 · see citing works

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease

Münch, G. W., Cunningham, A. M., Riederer, P. F., & Braak, E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00328-x · Cited by 57 · see citing works

Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?

Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55 · see citing works

Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components

Yen, S.-H. C., Liu, W.-K., Hall, F. L., Yan, S., Stern, D. M., & Dickson, D. W. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00022-7 · Cited by 53 · see citing works

Age-related changes of glutathione content, glucose transport and metabolism, and mitochondrial electron transfer function in mouse brain

Sasaki, T., Senda, M., Kim, S.-N., Kojima, S., & Kubodera, A. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00180-3 · Cited by 46 · see citing works

Age and GSH metabolism in rat cerebral cortex, as related to oxidative and energy parameters

Iantomasi, T., Favilli, F., Marraccini, P., Stio, M., Treves, C., Quatrone, A., Capaccioli, S., & VINCENZINI, M. T. (1993) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(93)90060-5 · Cited by 45 · see citing works

Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia

Fiebich, B. L., Lieb, K., Kammerer, N., & Hüll, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01822.x · Cited by 44 · see citing works

Micronutrients and Alzheimer's disease

Staehelin, H. B. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2005459 · Cited by 44 · see citing works

Growth hormone administration to aged animals reduces disulfide glutathione levels in hippocampus

Donahue, A., Aschner, M., Lash, L. H., Syversen, T. L. M., & Sonntag, W. E. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.003 · Cited by 44 · see citing works

Metal homeostasis in Alzheimer’s disease

White, A. R., Barnham, K. J., & Bush, A. I. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.711 · Cited by 42 · see citing works

Implication of Altered Redox Regulation by Antioxidant Enzymes in the Increased Plasma Pentosidine, an Advanced Glycation End Product, in Uremia

Ueda, Y., Miyata, T., Hashimoto, T., Yamada, H., Izuhara, Y., Sakai, H., & Kurokawa, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8523 · Cited by 40 · see citing works

The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared

Gsell, W., Strein, I., & Riederer, P. F. (1996) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6892-9_5 · Cited by 37 · see citing works

Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.

González, C., Farias, G. A., & Maccioni, R. B. (1998) · PubMed · Cited by 30 · see citing works

Determination of Glycation Crosslinking by the Sugar-Dependent Incorporation of [14C]Lysine into Protein

Prabhakaram, M., & ORTWERTH, B. J. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1046 · Cited by 29 · see citing works

Glycation

Colaco, C. A. L. S., & Harrington, C. R. (1994) · Neuroreport · doi:10.1097/00001756-199404000-00001 · Cited by 25 · see citing works

Tau glycation is involved in aggregation of the protein but not in the formation of filaments.

Ledesma, M. D., Pérez, M., Colaco, C. A. L. S., & Ávila, J. (1998) · PubMed · Cited by 25 · see citing works

In vivo phosphorylation in the rat basal nucleus induces PHF-like and APP immunoreactivity

Arendt, T., Hanisch, F., Holzer, M., & Bruckner, M. K. (1994) · Neuroreport · doi:10.1097/00001756-199406000-00027 · Cited by 23 · see citing works

Preliminary characterization of bovine pineal prolactin releasing (PPRF) and release-inhibiting factor (PPIF) activity

Chang, N., EBELS, I., & Benson, B. (1979) · Journal of Neural Transmission · doi:10.1007/bf01250335 · Cited by 23 · see citing works

Neue Hypothese zur Ätiopathogenese des Alzheimer-Syndroms Advanced glycation endproducts (AGEs)

Thome, J., Kornhuber, J., Münch, G., Schinzel, R., Taneli, Y., Zielke, B., Rösler, M., & Riederer, P. (1996) · Der Nervenarzt · doi:10.1007/s001150050073 · Cited by 19 · see citing works

Neurochemical abnormalities in Alzheimer’s disease and Parkinson’s disease — a comparative review

Gsell, W., Strein, I., Krause, U., & Riederer, P. F. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_12 · Cited by 16 · see citing works

Reversible in vivo phosphorylation of tau induced by okadaic acid and by unspecific brain lesion in rat.

Janke, C., Gärtner, U., Holzer, M., & Arendt, T. (1998) · PubMed · Cited by 10 · see citing works

Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications

Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 726 · see citing works

Brain metabolic dysfunction at the core of Alzheimer's disease

de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 462 · see citing works

Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders

Singh, S. K., Srivastav, S., Castellani, R. J., Plascencia‐Villa, G., & Perry, G. L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00767-8 · Cited by 402 · see citing works

Amyloid Beta in Aging and Alzheimer’s Disease

Sehar, U., Rawat, P., Reddy, A. P., Kopel, J. J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112924 · Cited by 385 · see citing works

Heavy Metals Exposure and Alzheimer’s Disease and Related Dementias

Bakulski, K. M., Seo, Y. A., Hickman, R. C., Brandt, D. J., Vadari, H. S., Hu, H., & Park, S. K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200282 · Cited by 355 · see citing works

PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease

Oksanen, M., Petersen, A. J., Naumenko, N., Puttonen, K., Lehtonen, Š., Gubert Olivé, M., Shakirzyanova, A., Leskelä, S., Sarajärvi, T., Viitanen, M., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.016 · Cited by 332 · see citing works

Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor

Brus, B., Košak, U., Turk, S., Pišlar, A. H., Coquelle, N., Kos, J., Stojan, J., Colletier, J., & Gobec, S. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501195e · Cited by 289 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics

Cassidy, L., Fernandez, F., Johnson, J. B., Naiker, M., Owoola, A. G., & Broszczak, D. A. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102294 · Cited by 283 · see citing works

Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases

Maiti, P., & Dunbar, G. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061637 · Cited by 236 · see citing works

The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?

Razani, E., Pourbagheri‐Sigaroodi, A., Safaroghli‐Azar, A., Zoghi, A., Bavarsad, M. S., & Bashash, D. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01231-3 · Cited by 229 · see citing works

Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades

Matos, M., Augusto, E., Oliveira, C. R., & Agostinho, P. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.022 · Cited by 223 · see citing works

Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease

Bhatia, V., & Sharma, S. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117253 · Cited by 226 · see citing works

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220 · see citing works

Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease

Bolea, I., Juárez‐Jiménez, J., Rı́os, C. D. L., Chioua, M., Pouplana, R., Luque, F. J., Unzeta, M., Marco, J. L., & Samadi, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200853t · Cited by 220 · see citing works

Multifunctional compounds: Smart molecules for multifactorial diseases

Bansal, Y., & Silakari, O. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.060 · Cited by 215 · see citing works

Elevated Oxidative Stress and Decreased Antioxidant Function in the Human Hippocampus and Frontal Cortex with Increasing Age: Implications for Neurodegeneration in Alzheimer’s Disease

Venkateshappa, C., Harish, G., Mahadevan, A., Srinivas Bharath, M. M., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0755-8 · Cited by 232 · see citing works

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

Valente, T., Gella, A., Fernàndez‐Busquets, X., Unzeta, M., & Durany, N. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.09.008 · Cited by 210 · see citing works

Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer’s Disease: Role of Glutathione and Metal Ions

Roy, R. G., Mandal, P. K., & Maroon, J. C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00486 · Cited by 194 · see citing works

Ginkgo biloba Extract in Alzheimer’s Disease: From Action Mechanisms to Medical Practice

Shi, C., Liu, J., Wu, F., & Yew, D. T. W. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11010107 · Cited by 186 · see citing works

Acetylene Group, Friend or Foe in Medicinal Chemistry

Talele, T. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01617 · Cited by 186 · see citing works

Neuroprotective effect of hesperetin and nano-hesperetin on recognition memory impairment and the elevated oxygen stress in rat model of Alzheimer’s disease

kheradmand, E., Moghaddam, A. H., & Zare, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.047 · Cited by 171 · see citing works

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

Košak, U., Brus, B., Knez, D., Žakelj, S., Trontelj, J., Pišlar, A. H., Šink, R., Jukič, M., Živin, M., Podkowa, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01086 · Cited by 166 · see citing works

Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer’s disease

Romero, A., Cacabelos, R., Oset‐Gasque, M. J., Samadi, A., & Marco, J. L. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.02.017 · Cited by 159 · see citing works

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors

Bolea, I., Gella, A., & Unzeta, M. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0948-y · Cited by 158 · see citing works

Nanoparticle and other metal chelation therapeutics in Alzheimer disease

Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G. L., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 160 · see citing works

Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease

Gupta, J., Fatima, M. T., Islam, Z., Khan, R. H., Uversky, V. N., & Salahuddin, P. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.156 · Cited by 160 · see citing works

Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration

Enciu, A., Gherghiceanu, M., & Popescu, B. O. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/297512 · Cited by 150 · see citing works

Glutathione Participation in the Prevention of Cardiovascular Diseases

Matuz‐Mares, D., Riveros‐Rosas, H., Vilchis‐Landeros, M. M., & Vázquez‐Meza, H. (2021) · Antioxidants · doi:10.3390/antiox10081220 · Cited by 149 · see citing works

Beneficial Role of Carica papaya Extracts and Phytochemicals on Oxidative Stress and Related Diseases: A Mini Review

Kong, Y. R., Jong, Y. X., Balakrishnan, M., Bok, Z. K., Weng, J. K. K., Tay, K. C., Goh, B. H., Ong, Y. S., Chan, K., Lee, L., et al. (2021) · Biology · doi:10.3390/biology10040287 · Cited by 168 · see citing works

Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases

Selvaraj, N. R., Nandan, D., Nair, B. J. B., Nair, V. A., Venugopal, P., & Aradhya, R. (2025) · Cells · doi:10.3390/cells14070511 · Cited by 147 · see citing works

Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants

Sanmartín‐Suárez, C., Soto‐Otero, R., Sánchez‐Sellero, I., & Méndez‐Álvarez, E. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.10.004 · Cited by 146 · see citing works

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease

Tajima, Y., Ishikawa, M., Maekawa, K., Murayama, M., Senoo, Y., Nishimaki‐Mogami, T., Nakanishi, H., Ikeda, K., Arita, M., Taguchi, R., et al. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-68 · Cited by 146 · see citing works

Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil–indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease

Bautista‐Aguilera, Ó. M., Esteban, G., Bolea, I., Nikolic, K. M., Agbaba, D., Moraleda, I., Iriepa, I., Samadi, A., Soriano, E., Unzeta, M., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.028 · Cited by 144 · see citing works

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

Wang, L., Esteban, G., Ojima, M., Bautista‐Aguilera, Ó. M., Inokuchi, T., Moraleda, I., Iriepa, I., Samadi, A., Youdim, M. B. H., Romero, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.078 · Cited by 143 · see citing works

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview

Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 142 · see citing works

Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease

Sharma, C., & Kim, S. R. (2021) · Antioxidants · doi:10.3390/antiox10081231 · Cited by 136 · see citing works

Oxidative Stress in Alzheimer's Disease and Mild Cognitive Impairment with High Sensitivity and Specificity

López, N., Tormo, C., Blas, I. D., Llinares, I., & Alom, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121528 · Cited by 133 · see citing works

Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion

Tavares, L., Figueira, I., Macedo, D., McDougall, G. J., Leitão, M. C., Vieira, H. L. A., Stewart, D., Alves, P. M., Ferreira, R. B., & dos Santos, C. N. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.10.025 · Cited by 130 · see citing works

Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases

Tabassum, R., & Jeong, N. Y. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.36516 · Cited by 129 · see citing works

Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?

Mazzanti, G., & Giacomo, S. D. (2016) · Molecules · doi:10.3390/molecules21091243 · Cited by 130 · see citing works

Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer’s pathology

Haure-Mirande, J.-V., Audrain, M., Fanutza, T., Kim, S. H., Klein, W. L., Glabe, C., Readhead, B., Dudley, J. T., Blitzer, R. D., Wang, M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1737-3 · Cited by 127 · see citing works

The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers

Sayeed, M. S. B., Asaduzzaman, M., Morshed, H., Hossain, M. M., Kadir, M. F., & Rahman, M. R. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.05.004 · Cited by 127 · see citing works

Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease

Joubert, J., Foka, G. B., Repsold, B. P., Oliver, D. W., Kapp, E., & Malan, S. F. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.041 · Cited by 123 · see citing works

The link of organophosphorus pesticides with neurodegenerative and neurodevelopmental diseases based on evidence and mechanisms

Mostafalou, S., & Abdollahi, M. R. (2018) · Toxicology · doi:10.1016/j.tox.2018.07.014 · Cited by 122 · see citing works

Natural product coumarins: biological and pharmacological perspectives

Hussain, M. I., Syed, Q. A., Khattak, M. N. K., Hafez, B., Reigosa, M. J., & El‐Keblawy, A. (2019) · Biologia · doi:10.2478/s11756-019-00242-x · Cited by 122 · see citing works

Telomere Shortening and Alzheimer’s Disease

Cai, Z., Yan, L., & Ratka, A. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8207-9 · Cited by 120 · see citing works

Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymes

Sağlık, B. N., Ilgın, S., & Özkay, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.042 · Cited by 116 · see citing works

Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass

Bonda, D., Wang, X., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1424-x · Cited by 113 · see citing works

Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments

Rodríguez-Giraldo, M., González-Reyes, R., Ramírez-Guerrero, S., Bonilla-Trilleras, C. E., Guardo-Maya, S., & Nava-Mesa, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113630 · Cited by 98 · see citing works

Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: A theoretical review

Salminen, L. E., & Paul, R. H. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0046 · Cited by 113 · see citing works

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Kumar, A., Pintus, F., Petrillo, A. D., Medda, R., Caria, P., Matos, M. J., Viña, D., Pieroni, E., Delogu, F., Era, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22747-2 · Cited by 112 · see citing works

Theories of Aging and the Prevalence of Alzheimer’s Disease

Trevisan, K., Cristina-Pereira, R., Silva-Amaral, D., & Aversi‐Ferreira, T. A. (2019) · BioMed Research International · doi:10.1155/2019/9171424 · Cited by 111 · see citing works

Alzheimer’ s disease, oxidative stress and gammahydroxybutyrate

Mamelak, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.008 · Cited by 108 · see citing works

Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress

Chiang, M., Nicol, C. J. B., & Cheng, Y. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.10.002 · Cited by 109 · see citing works

Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

Mishra, C. B., Kumari, S., Manral, A., Prakash, A., Saini, V., Lynn, A. M., & Tiwari, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.057 · Cited by 108 · see citing works

Brain Endothelial Cells Synthesize Neurotoxic Thrombin in Alzheimer’s Disease

Yin, X., Wright, J., Wall, T., & Grammas, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090406 · Cited by 104 · see citing works

Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation

Wu, M., Esteban, G., Brogi, S., Shionoya, M., Wang, L., Campiani, G., Unzeta, M., Inokuchi, T., Butini, S., & Marco‐Contelles, J. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.001 · Cited by 104 · see citing works

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy

Amemori, T., Jendelová, P., Růžička, J., Urdzíková, L. M., & Syková, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 102 · see citing works

Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed

de la Monte, S. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111727 · Cited by 101 · see citing works

Potential oxidative stress biomarkers of mild cognitive impairment due to Alzheimer disease

García‐Blanco, A., Baquero, M., Vento, M., Gil, E., Bataller, L., & Cháfer‐Pericás, C. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.020 · Cited by 101 · see citing works

Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities

Knez, D., Coquelle, N., Pišlar, A. H., Žakelj, S., Jukič, M., Sova, M., Mravljak, J., Nachon, F., Brazzolotto, X., Kos, J., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.033 · Cited by 99 · see citing works

Curcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy

Jaroonwitchawan, T., Chaicharoenaudomrung, N., Namkaew, J., & Noisa, P. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.050 · Cited by 97 · see citing works

Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer’s disease

Kitamura, Y., Usami, R., Ichihara, S., Kida, H., Satoh, M., Tomimoto, H., Murata, M., & Oikawa, S. (2017) · Neurological Research · doi:10.1080/01616412.2017.1281195 · Cited by 97 · see citing works

Attenuation of β -Amyloid-Induced Oxidative Cell Death by Sulforaphane via Activation of NF-E2-Related Factor 2

Lee, C., Park, G. H., Lee, S., & Jang, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/313510 · Cited by 97 · see citing works

Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 95 · see citing works

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease

Singh, Y. P., Rai, H., Singh, G., Singh, G. K., Mishra, S. K., Kumar, S., Srikrishna, S., & Modi, G. P. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113278 · Cited by 95 · see citing works

Urate and risk of Alzheimer's disease and vascular dementia: A population‐based study

Scheepers, L. E. J. M., Jacobsson, L., Kern, S., Johansson, L. H., Dehlin, M., & Skoog, I. G. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.01.014 · Cited by 92 · see citing works

A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease

Umar, T., Shalini, S., Raza, M. K., Gusain, S., Kumar, J., Seth, P., Tiwari, M., & Hoda, N. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.038 · Cited by 89 · see citing works

Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease

Birla, H., Minocha, T., Kumar, G., Misra, A., & Singh, S. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200122122512 · Cited by 89 · see citing works

Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice

Matthews, D. G., Caruso, M., Murchison, C. F., Zhu, J. Y., Wright, K. M., Harris, C. J., Gray, N. E., Quinn, J. F., & Soumyanath, A. (2019) · Antioxidants · doi:10.3390/antiox8120630 · Cited by 86 · see citing works

Icariin and Its Metabolites as Potential Protective Phytochemicals Against Alzheimer’s Disease

Angeloni, C., Barbalace, M. C., & Hrelia, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00271 · Cited by 86 · see citing works

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways

Demuro, S., Martino, R. M. C. D., Ortega, J. A., & Cavalli, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169098 · Cited by 86 · see citing works

The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease

Ogunmokun, G., Dewanjee, S., Chakraborty, P., Valupadas, C., Chaudhary, A., Kolli, V., Anand, U., Vallamkondu, J., Goel, P., Paluru, H. P. R., et al. (2021) · Cells · doi:10.3390/cells10102790 · Cited by 85 · see citing works

Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer’s disease treatment

Minarini, A., Milelli, A., Tumiatti, V., Rosini, M., Simoni, E., Bolognesi, M. L., Andrisano, V., Bartolini, M., Motori, E., Angeloni, C., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.007 · Cited by 85 · see citing works

Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases

Dhahri, M., Alghrably, M., Mohammed, H. A., Badshah, S. L., Noreen, N., Mouffouk, F., Rayyan, S., Qureshi, K. A., Mahmood, D., Lachowicz, J. I., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010001 · Cited by 86 · see citing works

Tinospora cordifolia (Willd.) Miers: Protection mechanisms and strategies against oxidative stress-related diseases

Arunachalam, K., Yang, X., & San, T. T. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114540 · Cited by 82 · see citing works

Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus

Ogama, N., Sakurai, T., Kawashima, S., Tanikawa, T., Tokuda, H., Satake, S., Miura, H., Shimizu, A., Kokubo, M., Niida, S., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030319 · Cited by 81 · see citing works

Molecular Basis of Etiological Implications in Alzheimer’s Disease: Focus on Neuroinflammation

Niranjan, R. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8428-4 · Cited by 81 · see citing works

Protective effect of daidzein against streptozotocin‐induced Alzheimer's disease via improving cognitive dysfunction and oxidative stress in rat model

Wei, J., Yang, F., Gong, C., Shi, X., & Wang, G. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22319 · Cited by 77 · see citing works

New tetracyclic tacrine analogs containing pyrano[2,3-c]pyrazole: Efficient synthesis, biological assessment and docking simulation study

Khoobi, M., Ghanoni, F., Nadri, H., Moradi, A., Hamedani, M. P., Moghadam, F. H., Emami, S., Vosooghi, M., Zadmard, R., Foroumadi, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.049 · Cited by 76 · see citing works

A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

Gadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2020) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 70 · see citing works

Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer’s Disease – A Translational Perspective

Apetz, N., Münch, G. W., Govindaraghavan, S., & Gyengési, E. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917110635 · Cited by 72 · see citing works

Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine

Samadi, A., Rı́os, C. D. L., Bolea, I., Chioua, M., Iriepa, I., Moraleda, I., Bartolini, M., Andrisano, V., Galvez‐Ruano, E., Valderas, C., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.022 · Cited by 71 · see citing works

Design and synthesis of novel anti-Alzheimer’s agents: Acridine-chromenone and quinoline-chromenone hybrids

Najafi, Z., Saeedi, M., Mahdavi, M. R., Sabourian, R., Khanavi, M., Tehrani, M. B., Moghadam, F. H., Edraki, N., Karimpor-Razkenari, E., Sharifzadeh, M. S., et al. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.06.001 · Cited by 71 · see citing works

Dietary Polyphenols as Therapeutic Intervention for Alzheimer’s Disease: A Mechanistic Insight

Bukhari, S. N. A. (2022) · Antioxidants · doi:10.3390/antiox11030554 · Cited by 70 · see citing works

Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease

Samadi, A., Chioua, M., Bolea, I., Rı́os, C. D. L., Iriepa, I., Moraleda, I., Bastida, Á., Esteban, G., Unzeta, M., Galvez‐Ruano, E., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.048 · Cited by 70 · see citing works

Hybrid Multifunctional Modulators Inhibit Multifaceted Aβ Toxicity and Prevent Mitochondrial Damage

Rajasekhar, K., Mehta, K., & Govindaraju, T. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00033 · Cited by 69 · see citing works

Oxidative stress and ion channels in neurodegenerative diseases

Orfali, R. S., Alwatban, A. Z., Orfali, R. S., Lau, L., Chea, N., Alotaibi, A. M., Nam, Y.-W., & Zhang, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1320086 · Cited by 68 · see citing works

An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission

Akyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69 · see citing works

Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease: Insights into Pathophysiology and Treatment

Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66 · see citing works

Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection

Peña‐Bautista, C., Vigor, C., Galano, J., Oger, C., Durand, T., Ferrer, I., Cuevas, A., López‐Cuevas, R., Baquero, M., López‐Nogueroles, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.038 · Cited by 66 · see citing works

Alzheimer’s Disease, Cholesterol, and Statins: The Junctions of Important Metabolic Pathways

Silva, T., Teixeira, J., Remião, F., & Borges, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204964 · Cited by 65 · see citing works

Positive Feedback Loops in Alzheimer’s Disease: The Alzheimer’s Feedback Hypothesis

Doig, A. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180583 · Cited by 64 · see citing works

Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model

Niño, S. A., Morales-Martínez, A., Chi-Ahumada, É., Carrizales, L., Salgado‐Delgado, R., Pérez‐Severiano, F., Díaz-Cintra, S. Y., Jiménez-Capdeville, M. E., & Zarazúa, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00278 · Cited by 64 · see citing works

Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants

Chakrabarti, S., Sinha, M., Thakurta, I. G., Banerjee, P., & Chattopadhyay, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990152 · Cited by 63 · see citing works

Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease

Atlante, A., Amadoro, G., Bobba, A., & Latina, V. (2020) · Cells · doi:10.3390/cells9112347 · Cited by 64 · see citing works

Oxidative Stress

Ortíz, G. G., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Flores-Alvarado, L. J., González-Usigli, H., Sánchez-González, V., Sánchez-López, A. L., Sánchez-Romero, L., Díaz-Barba, E. I., Gutiérrez, J. F. S., et al. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.003 · Cited by 62 · see citing works

The Role of Dietary Antioxidants in the Pathogenesis of Neurodegenerative Diseases and Their Impact on Cerebral Oxidoreductive Balance

Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 61 · see citing works

Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements

Poddar, J., Pradhan, M., Ganguly, G., & Chakrabarti, S. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.04.002 · Cited by 62 · see citing works

Investigations on oxidative stress and therapeutical implications in dementia

Durany, N., Münch, G. W., Michel, T. M., & Riederer, P. F. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014177 · Cited by 88 · see citing works

Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability

Uddin, M. S., & Kabir, M. T. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_5 · Cited by 49 · see citing works

Euro Neuropharmacology 2018: The oxidative stress initiated mitochondrial DNA over proliferation and deletion in the context of the cancer and neurodegeneration: Recent challenge in Neuropharmacology - Gjumrakch Aliev - University of Atlanta

Aliev, G. M. (2020) · Journal of Clinical Medicine and Therapeutics

Oxidativer Streß in der Pathogenese von Morbus Alzheimer und antioxidative Neuroprotektion

Behl, C., & Holsboer, F. (1998) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-995246 · Cited by 39 · see citing works

Glycoxidative stress creates a vicious cycle of neurodegeneration in Alzheimer’s disease — a target for neuroprotective treatment strategies?

Münch, G. W., Deuther‐Conrad, W., & Gasic‐Milenkovic, J. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_28 · Cited by 45 · see citing works